4.5 Article

Comparative Effectiveness, Safety, and Real-World Outcomes of a Nurse-Led, Protocol-Driven Penicillin Allergy Evaluation From the Hong Kong Drug Allergy Delabelling Initiative (HK-DADI)

Related references

Note: Only part of the references are listed.
Article Allergy

Safe De-Labeling of Patients at Low Risk of Penicillin Allergy in Denmark

Sara Fransson et al.

Summary: This study investigated the rate of severe allergic reactions to direct oral drug provocation in penicillin allergy patients stratified to be at low risk, as well as barriers to penicillin allergy de-labeling and future use of penicillins. The results showed that direct oral provocation without preceding tests was safe in low-risk patients, with no cases of anaphylaxis or severe delayed hypersensitivity. However, benign delayed skin reactions still occurred.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2022)

Article Allergy

Experience of the first 1127 COVID-19 Vaccine Allergy Safety patients in Hong Kong-Clinical outcomes, barriers to vaccination, and urgency for reform

Valerie Chiang et al.

Summary: Hong Kong has a low incidence of COVID-19 vaccine related anaphylaxis, due in part to its Vaccine Allergy Safety (VAS) guidelines. The majority of patients assessed at VAS clinics were recommended for vaccination, but there were still unnecessary referrals that caused some rejections in the public vaccination program.

WORLD ALLERGY ORGANIZATION JOURNAL (2022)

Article Pharmacology & Pharmacy

Effectiveness and Feasibility of Pharmacist-Driven Penicillin Allergy De-Labeling Pilot Program without Skin Testing or Oral Challenges

You-Chan Song et al.

Summary: In this study, researchers effectively and feasibly removed penicillin allergies in patients without a true allergy using a pharmacist-led standardized checklist.

PHARMACY (2021)

Article Allergy

Safety and efficacy of direct two-step penicillin challenges with an inpatient pharmacist-driven allergy evaluation

YoungYoon Ham et al.

Summary: A pharmacist-driven penicillin allergy evaluation program focusing on direct oral graded challenges and bypassing PST can effectively delabel admitted patients, optimizing antibiotic treatment. However, more safety data are needed before implementing similar programs.

ALLERGY AND ASTHMA PROCEEDINGS (2021)

Article Medicine, General & Internal

Epidemiology and outcomes of geriatric and non-geriatric patients with drug allergy labels in Hong Kong

Philip H. Li et al.

Summary: More than 13% of hospitalised geriatric patients had drug allergy labels, with cardiovascular system drugs being a common allergen. Geriatric patients had a significantly lower rate of direct discharge from the hospital and required more transfers for further care, highlighting the importance of managing drug allergies in this population.

HONG KONG MEDICAL JOURNAL (2021)

Article Oncology

Penicillin Allergy Testing An outpatient nurse-driven program for patients with cancer

Sejal Morjaria et al.

Summary: By implementing an oncology outpatient nurse-driven PAT program, 82 outpatients with reported penicillin allergies were screened from November 2018 to December 2019, with 90% eligible for testing and 97% testing negative for penicillin allergy. There was also a significant reduction in aztreonam use among patients admitted for hematopoietic stem cell transplantation compared to before PAT was offered.

CLINICAL JOURNAL OF ONCOLOGY NURSING (2021)

Article Medicine, General & Internal

Prevalence, Incidence, and Sensitization Profile of β-lactam Antibiotic Allergy in Hong Kong

Philip H. Li et al.

JAMA NETWORK OPEN (2020)

Article Medicine, General & Internal

Prevalence and Impact of Reported Drug Allergies among Rheumatology Patients

Shirley Chiu Wai Chan et al.

DIAGNOSTICS (2020)

Article Infectious Diseases

Implementation of a pharmacist-led penicillin allergy de-labelling service in a public hospital

Tanya du Plessis et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)

Review Infectious Diseases

Self-reported beta-lactam intolerance: not a class effect, dangerous to patients, and rarely allergy

David Vyles et al.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2019)

Article Allergy

Comparing Direct Challenge to Penicillin Skin Testing for the Outpatient Evaluation of Penicillin Allergy: A Randomized Controlled Trial

S. Shahzad Mustafa et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)

Article Allergy

Beta-lactam allergy in Chinese patients and factors predicting genuine allergy

Philip Hei Li et al.

WORLD ALLERGY ORGANIZATION JOURNAL (2019)

Review Medicine, General & Internal

Evaluation and Management of Penicillin Allergy A Review

Erica S. Shenoy et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Review Allergy

The Cost of Self-Reported Penicillin Allergy: A Systematic Review

T. Joseph Mattingly et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2018)

Article Allergy

Management of allergy to penicillins and other beta-lactams

R. Mirakian et al.

CLINICAL AND EXPERIMENTAL ALLERGY (2015)

Review Allergy

Penicillin and Beta-Lactam Allergy: Epidemiology and Diagnosis

Eric Macy

CURRENT ALLERGY AND ASTHMA REPORTS (2014)

Article Allergy

Multiple drug intolerance syndrome: prevalence, clinical characteristics, and management

Eric Macy et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2012)

Article Allergy

Self-reported drug allergy in a general adult Portuguese population

E Gomes et al.

CLINICAL AND EXPERIMENTAL ALLERGY (2004)

Article Medicine, General & Internal

Costs of β-lactam allergies -: Selection and costs of antibiotics for patients with a reported β-lactam allergy

EJ MacLaughlin et al.

ARCHIVES OF FAMILY MEDICINE (2000)